Indapamida Tarbis

Indapamide, the active ingredient in Indapamida Tarbis, is a thiazide-like diuretic presented as an oral tablet for oral use. It treats hypertension and edema in adult patients.

GNH USA supplies Indapamida Tarbis as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide is used as an antihypertensive and diuretic to manage conditions related to fluid overload and high blood pressure.

- Hypertension: lowers systolic and diastolic blood pressure to target levels. - Edema: increases urinary excretion of sodium and water, reducing peripheral swelling. - Congestive heart failure: assists in volume control and symptom relief.

Indapamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness or light‑headedness. - Headache. - Increased frequency of urination. - Electrolyte imbalance, especially low potassium. - Muscle cramps. - Fatigue.

Serious or Rare Side Effects: - Severe dehydration or hypovolemia. - Hyponatremia or profound hypokalemia. - Acute gout attacks. - Allergic reactions such as rash or angioedema. - Blood disorders including leukopenia or thrombocytopenia.

Before initiating therapy, clinicians should consider several safety measures.

- Monitor electrolytes: check serum potassium and sodium regularly. - Assess renal function: avoid use in severe renal impairment. - Evaluate blood pressure: watch for hypotension, especially after the first dose. - Consider gout history: diuretics can precipitate gout flares. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at room temperature: keep in the original container, protect from moisture and light.

Indapamide can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Lithium: risk of lithium toxicity due to reduced clearance. - NSAIDs: may blunt the diuretic effect and increase renal risk. - ACE inhibitors or ARBs: combined use can cause severe hypotension and renal impairment.

Moderate Interactions (Monitor Closely): - Digoxin: electrolyte shifts may alter digoxin levels. - Antidiabetic agents: enhanced hypoglycaemic effect may occur. - Corticosteroids: may increase potassium loss and exacerbate electrolyte disturbances.